OMG! How extraordinarily outrageous. Allison Tomek doesn't risk concern with callers looking to trade upon information that has not been formally made available to the public? If shareholders are to retain value in the company, its personnel must obviously be distracted by legal accusations at every turn. Really. It is as bad as a pharmaceutical company providing updates to patient enrollment in clinical trials without providing their personalized medical details/outcome.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.